| 日付 | 受信時刻 | ニュースソース | 見出し | コード | 企業名 |
| 2007/02/16 | 22 : 30 | PR Newswire (US) | GlaxoSmithKline Successfully Completes Tender Offer for Shares of PRAECIS PHARMACEUTICALS | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |
| 2007/02/16 | 22 : 30 | PR Newswire (US) | GlaxoSmithKline Successfully Completes Tender Offer for Shares of PRAECIS PHARMACEUTICALS | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |
| 2007/02/15 | 23 : 00 | PR Newswire (US) | GlaxoSmithKline Extends Subsequent Offering Period By One Day | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |
| 2007/02/07 | 23 : 11 | PR Newswire (US) | GlaxoSmithKline Accepts Shares in Tender Offer for Shares of PRAECIS PHARMACEUTICALS and Commences Subsequent Offering Period | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |
| 2007/01/09 | 23 : 03 | PR Newswire (US) | GlaxoSmithKline Commences Tender Offer to Acquire PRAECIS PHARMACEUTICALS | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |
| 2006/11/09 | 21 : 15 | Business Wire | PRAECIS PHARMACEUTICALS INCORPORATED Reports Third Quarter 2006 Financial Results | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |
| 2006/11/08 | 21 : 00 | Business Wire | PRAECIS PHARMACEUTICALS INCORPORATED Presents Interim Clinical Data on PPI-2458 at the 18th EORTC-NCI-AACR Symposium | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |
| 2006/11/02 | 04 : 02 | Business Wire | PRAECIS PHARMACEUTICALS INCORPORATED To Announce Third Quarter Financial Results on Thursday, November 9, 2006 | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |
| 2006/10/24 | 20 : 00 | Business Wire | PRAECIS PHARMACEUTICALS INCORPORATED Receives the Cerep Award for Research Related to Its Investigational Drug Candidate, PPI-24 | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |
| 2006/10/18 | 20 : 00 | Business Wire | PRAECIS PHARMACEUTICALS INCORPORATED Presents Preclinical Data on PPI-2458 | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |
| 2006/08/04 | 20 : 00 | Business Wire | PRAECIS PHARMACEUTICALS INCORPORATED Reports Second Quarter 2006 Financial Results | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |
| 2006/08/02 | 05 : 30 | Business Wire | PRAECIS PHARMACEUTICALS INCORPORATED to Announce Second Quarter Financial Results on Friday, August 4, 2006 | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |
| 2006/06/20 | 20 : 00 | Business Wire | PRAECIS PHARMACEUTICALS INCORPORATED Announces Cessation of Plenaxis(R) Disposition Efforts; Plans to Explore Financing Alterna | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |
| 2006/05/05 | 20 : 00 | Business Wire | PRAECIS PHARMACEUTICALS INCORPORATED Reports First Quarter 2006 Financial Results | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |
| 2006/04/28 | 20 : 30 | Business Wire | PRAECIS PHARMACEUTICALS INCORPORATED To Announce First Quarter Financial Results on Friday, May 5, 2006 | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |
| 2006/04/20 | 21 : 00 | Business Wire | PRAECIS PHARMACEUTICALS INCORPORATED Appoints Prem Das as Senior Vice President, Technology Partnerships | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |
| 2006/04/10 | 20 : 30 | Business Wire | PRAECIS PHARMACEUTICALS INCORPORATED Announces Pilot Study and Option Agreement with GlaxoSmithKline to Utilize DirectSelect(TM | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |
| 2006/03/21 | 21 : 30 | Business Wire | PRAECIS PHARMACEUTICALS INCORPORATED Announces Technology Transfer and Option Agreement with Gilead Sciences, Inc. to Utilize D | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |
| 2006/03/15 | 22 : 30 | Business Wire | PRAECIS PHARMACEUTICALS INCORPORATED Presents Update on its DirectSelect(TM) Technology | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |
| 2006/03/10 | 04 : 00 | Business Wire | PRAECIS PHARMACEUTICALS INCORPORATED Presents Preclinical Data on PPI-2458 in Rheumatoid Arthritis | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |
| 2006/02/22 | 22 : 30 | Business Wire | PRAECIS PHARMACEUTICALS INCORPORATED Presents Update on its DirectSelect(TM) Technology | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |
| 2006/02/10 | 06 : 51 | Business Wire | PRAECIS PHARMACEUTICALS INCORPORATED Presents Preclinical Data on PPI-2458 | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |
| 2006/02/03 | 21 : 00 | Business Wire | PRAECIS PHARMACEUTICALS INCORPORATED Reports Fourth Quarter and Year End 2005 Financial Results | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |
| 2006/01/31 | 04 : 40 | Business Wire | PRAECIS PHARMACEUTICALS INCORPORATED To Announce Fourth Quarter and Year End 2005 Financial Results on Friday, February 3, 2006 | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |
| 2005/11/08 | 08 : 15 | Business Wire | PRAECIS PHARMACEUTICALS INCORPORATED To Present at the Rodman & Renshaw Techvest 7th Annual Healthcare Conference on November 9, | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |
| 2005/11/04 | 21 : 00 | Business Wire | PRAECIS PHARMACEUTICALS INCORPORATED Reports Third Quarter 2005 Financial Results | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |
| 2005/11/01 | 21 : 00 | Business Wire | PRAECIS PHARMACEUTICALS INCORPORATED To Announce Third Quarter 2005 Financial Results on Friday, November 4, 2005 | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |
| 2005/10/28 | 05 : 17 | Business Wire | PRAECIS PHARMACEUTICALS INCORPORATED Stockholders Authorize Reverse Stock Split; Board Sets 1-for-5 Split Ratio | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |
| 2005/10/19 | 20 : 00 | Business Wire | PRAECIS PHARMACEUTICALS INCORPORATED Completes Sale of Facility for $51.25 Million | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |
| 2005/10/11 | 22 : 12 | Business Wire | PRAECIS PHARMACEUTICALS INCORPORATED Announces Agreement for Sale of Facility | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |